UKBizDB.co.uk

AMO PHARMA LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Amo Pharma Limited. The company was founded 10 years ago and was given the registration number 09431909. The firm's registered office is in LEEDS. You can find them at 1 Park Row, , Leeds, . This company's SIC code is 72190 - Other research and experimental development on natural sciences and engineering.

Company Information

Name:AMO PHARMA LIMITED
Company Number:09431909
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:10 February 2015
Industry Codes:
  • 72190 - Other research and experimental development on natural sciences and engineering

Office Address & Contact

Registered Address:1 Park Row, Leeds, England, LS1 5AB
Country Origin:ENGLAND
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

People with Significant Control

Iiu Nominees Limited
Notified on:04 February 2020
Status:Active
Country of residence:Ireland
Address:Ifsc House, Custom House Quay, Dublin, Ireland, DO1 R2P9
Nature of control:
  • Significant influence or control
Mr Dermot Desmond
Notified on:04 February 2020
Status:Active
Date of birth:August 1950
Nationality:Irish
Country of residence:Ireland
Address:Iiu, C/O Legal Counsel, 5th Floor, Ifsc House, Custom House Quay, Dublin 1, Ireland, D01 R2P9
Nature of control:
  • Significant influence or control
Woodford Patient Capital Trust Plc
Notified on:06 April 2016
Status:Active
Country of residence:United Kingdom
Address:40, Dukes Place, London, United Kingdom, EC3A 7NH
Nature of control:
  • Ownership of shares 25 to 50 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (2 years ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (5 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (7 months remaining)

Copyright © 2025. All rights reserved.